Difference between revisions of "Part:BBa K3365059:Design"
(→Source) |
|||
Line 7: | Line 7: | ||
===Design Notes=== | ===Design Notes=== | ||
− | We choose additional antibiotic resistance genes that was not used before, kanamycin resistant gene as the alternatives to <i>rpoZ</i>, so that we can make a preliminary judgment with the medium containing kanamycin. Only the | + | |
+ | We choose additional antibiotic resistance genes that was not used before, kanamycin resistant gene as the alternatives to <i>rpoZ</i>, so that we can make a preliminary judgment with the medium containing kanamycin. Only the bacteria whose genome was knocked out <i>rpoZ</i> can survive in kanamycin resistant medium while others not. | ||
Latest revision as of 12:47, 27 October 2020
kanamycin resistant gene with homologous arms
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Design Notes
We choose additional antibiotic resistance genes that was not used before, kanamycin resistant gene as the alternatives to rpoZ, so that we can make a preliminary judgment with the medium containing kanamycin. Only the bacteria whose genome was knocked out rpoZ can survive in kanamycin resistant medium while others not.
Source
We get the sequence of homologous arm at both ends of rpoZ from reference and get the part of kanamycin resistant gene from pET28a contained kanamycin resistance through PCR.
References
[1]David Bikard,Wenyan Jiang,Poulami Samai,Ann Hochschild,Feng Zhang,Luciano A. Marraffini1.Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system[J]. Nucleic Acids Research,2013,41(15):7429-7437.